Back
Zealand Pharma AS Vs. Novo Nordisk AS Industry Stock Comparison
Sell
44
ZLDPF
Zealand Pharma AS
Last Price:
116.06
Seasonality Move:
5.91%
Sell
39
NVO
Novo Nordisk AS
Last Price:
106.91
Seasonality Move:
9.3%
Sell
44
Zealand Pharma AS (ZLDPF)
is a Sell
Is Zealand Pharma AS a Buy, Sell or Hold?
- The current Zealand Pharma AS [ZLDPF] share price is $116.06. The Score for ZLDPF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- ZLDPF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $106.91. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZLDPF Stock Price Chart
What is Zealand Pharma AS's stock price today?
-
The Zealand Pharma AS share price today is $116.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZLDPF is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $106.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
ZLDPF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 43.99 | Sell |
| Chaikin Money Flow: | -1351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.15 - 122.61) | Sell |
| Bollinger Bands (100): | (119.39 - 133.45) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.65 | Sell |
| Relative Strength Index (14 RSI): | 32.42 | Sell |
| Chaikin Money Flow: | -1293187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.83 - 117.55) | Sell |
| Bollinger Bands (100): | (116.87 - 138.83) | Sell |
ZLDPF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.96 | Sell |
| 20-day SMA: | 119.87 | Sell |
| 50-day SMA: | 122.67 | Sell |
| 200-day SMA: | 107.88 | Buy |
| 8-day EMA: | 120.55 | Sell |
| 20-day EMA: | 120.46 | Sell |
| 50-day EMA: | 121.54 | Sell |
| 200-day EMA: | 106.12 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.89 | Sell |
| 20-day SMA: | 111.88 | Sell |
| 50-day SMA: | 120 | Sell |
| 200-day SMA: | 128.26 | Sell |
| 8-day EMA: | 108.34 | Sell |
| 20-day EMA: | 111.5 | Sell |
| 50-day EMA: | 118.07 | Sell |
| 200-day EMA: | 121.79 | Sell |
Zealand Pharma AS Earnings Growth & ZLDPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.74 per share.
Zealand Pharma AS Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||